Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
bioRxiv ; 2023 Dec 04.
Article in English | MEDLINE | ID: mdl-38106167

ABSTRACT

In Alzheimer's disease (AD) pathophysiology, plaque and tangle accumulation trigger an inflammatory response that mounts positive feed-back loops between inflammation and protein aggregation, aggravating neurite damage and neuronal death. One of the earliest brain regions to undergo neurodegeneration is the locus coeruleus (LC), the predominant site of norepinephrine (NE) production in the central nervous system (CNS). In animal models of AD, dampening the impact of noradrenergic signaling pathways, either through administration of beta blockers or pharmacological ablation of the LC, heightened neuroinflammation through increased levels of pro-inflammatory mediators. Since microglia are the resident immune cells of the CNS, it is reasonable to postulate that they are responsible for translating the loss of NE tone into exacerbated disease pathology. Recent findings from our lab demonstrated that noradrenergic signaling inhibits microglia dynamics via ß2 adrenergic receptors (ß2ARs), suggesting a potential anti-inflammatory role for microglial ß2AR signaling. Thus, we hypothesize that microglial ß2 adrenergic signaling is progressively impaired during AD progression, which leads to the chronic immune vigilant state of microglia that worsens disease pathology. First, we characterized changes in microglial ß2AR signaling as a function of amyloid pathology. We found that LC neurons and their projections degenerate early and progressively in the 5xFAD mouse model of AD; accompanied by mild decrease in the levels of norepinephrine and its metabolite normetanephrine. Interestingly, while 5xFAD microglia, especially plaque-associated microglia, significant downregulated ß2AR gene expression early in amyloid pathology, they did not lose their responsiveness to ß2AR stimulation. Most importantly, we demonstrated that specific microglial ß2AR deletion worsened disease pathology while chronic ß2AR stimulation resulted in attenuation of amyloid pathology and associated neuritic damage, suggesting microglial ß2AR might be used as potential therapeutic target to modify AD pathology.

2.
Brain Behav Immun ; 101: 288-303, 2022 03.
Article in English | MEDLINE | ID: mdl-35065196

ABSTRACT

Recent studies have shown that the aryl hydrocarbon receptor (AhR) is expressed in the brain's native immune cells, known as microglia. However, while the impact of exposure to AhR ligands is well studied in the peripheral immune system, the impact of such exposure on immune function in the brain is less well defined. Microglia serve dual roles in providing synaptic and immunological support for neighboring neurons and in mediating responses to environmental stimuli, including exposure to environmental chemicals. Because of their dual roles in regulating physiological and pathological processes, cortical microglia are well positioned to translate toxic stimuli into defects in cortical function via aberrant synaptic and immunological functioning, mediated either through direct microglial AhR activation or in response to AhR activation in neighboring cells. Here, we use gene expression studies, histology, and two-photon in vivo imaging to investigate how developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a high-affinity and persistent AhR agonist, modulates microglial characteristics and function in the intact brain. Whole cortical RT-qPCR analysis and RNA-sequencing of isolated microglia revealed that gestational and lactational TCDD exposure produced subtle, but durable, changes in microglia transcripts. Histological examination and two-photon in vivo imaging revealed that while microglia density, distribution, morphology, and motility were unaffected by TCDD exposure, exposure resulted in microglia that responded more robustly to focal tissue injury. However, this effect was rectified with depletion and repopulation of microglia. These results suggest that gestational and lactational exposure to AhR ligands can result in long-term priming of microglia to produce heightened responses towards tissue injury which can be restored to normal function through microglial repopulation.


Subject(s)
Polychlorinated Dibenzodioxins , Female , Humans , Lactation , Ligands , Microglia/metabolism , Polychlorinated Dibenzodioxins/metabolism , Polychlorinated Dibenzodioxins/toxicity
3.
Neurosci Lett ; 742: 135516, 2021 01 18.
Article in English | MEDLINE | ID: mdl-33227371

ABSTRACT

Microglia, the immune cells of the brain, have a canonical role in regulating responses to neurological disease or injury, but have also recently been implicated as regulators of neurophysiological processes such as learning and memory. Given these dual immune and physiological roles, microglia are a likely mechanism by which external toxic stimuli are converted into deficits in neuronal circuitry and subsequently function. However, while it is well established that exposure to environmental toxicants negatively affects the peripheral immune system, it remains unknown whether and how such exposure causes neuroinflammation which, in turn, may negatively impact microglial functions in vivo. Here, we examined how acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in adulthood, which negatively impacts immune cells in the periphery, affects microglial characteristics in the cortex of the mouse. We found that microglia density, distribution, morphology, inflammatory signaling, and response to a secondary, pathological activation were unaffected by acute TCDD exposure. These results suggest that acute, peripheral TCDD exposure in adulthood is not sufficient to induce an overt inflammatory phenotype in cortical microglia.


Subject(s)
Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Environmental Pollutants/toxicity , Microglia/drug effects , Microglia/metabolism , Polychlorinated Dibenzodioxins/toxicity , Animals , Cerebral Cortex/pathology , Female , Male , Mice , Mice, Inbred C57BL , Microglia/pathology
4.
Nat Commun ; 7: 10905, 2016 Mar 07.
Article in English | MEDLINE | ID: mdl-26948129

ABSTRACT

Microglia are the resident immune cells of the brain. Increasingly, they are recognized as important mediators of normal neurophysiology, particularly during early development. Here we demonstrate that microglia are critical for ocular dominance plasticity. During the visual critical period, closure of one eye elicits changes in the structure and function of connections underlying binocular responses of neurons in the visual cortex. We find that microglia respond to monocular deprivation during the critical period, altering their morphology, motility and phagocytic behaviour as well as interactions with synapses. To explore the underlying mechanism, we focused on the P2Y12 purinergic receptor, which is selectively expressed in non-activated microglia and mediates process motility during early injury responses. We find that disrupting this receptor alters the microglial response to monocular deprivation and abrogates ocular dominance plasticity. These results suggest that microglia actively contribute to experience-dependent plasticity in the adolescent brain.


Subject(s)
Microglia/metabolism , Neuronal Plasticity , Receptors, Purinergic P2Y12/metabolism , Visual Cortex/physiology , Animals , Dominance, Ocular , Mice , Mice, Inbred C57BL , Neurons/metabolism , Receptors, Purinergic P2Y12/genetics , Synapses/genetics , Synapses/metabolism
5.
Genesis ; 31(4): 142-6, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11783004

ABSTRACT

Mouse embryos homozygous for the allele eed(l7Rn5-3354SB) of the Polycomb Group gene embryonic ectoderm development (eed) display a gastrulation defect in which epiblast cells move through the streak and form extraembryonic mesoderm derivatives at the expense of development of the embryo proper. Here we demonstrate that homozygous mutant ES cells have the capacity to differentiate embryonic cell types both in vitro as embryoid bodies and in vivo as chimeric embryos. In chimeric embryos, eed mutant cells can respond to wild-type signals and participate in normal gastrulation movements. These results indicate a non-cell-autonomous function for eed. Evidence of mutant cell exclusion from the forebrain and segregation within somites, however, suggests that eed has cell-autonomous roles in aspects of organogenesis. A requirement for eed in the epiblast during embryonic development is supported by the fact that high-contribution chimeras could not be rescued by a wild-type extraembryonic environment.


Subject(s)
Embryonic and Fetal Development/physiology , Gastrula/physiology , Gene Expression/physiology , Repressor Proteins/physiology , Alleles , Animals , Cell Line , Chimera , Embryonic and Fetal Development/genetics , Mice , Mice, Inbred C57BL , Mutation , Polycomb Repressive Complex 2 , Repressor Proteins/genetics , Stem Cells/physiology
6.
J Cell Biol ; 141(5): 1277-86, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9606218

ABSTRACT

Lumican, a prototypic leucine-rich proteoglycan with keratan sulfate side chains, is a major component of the cornea, dermal, and muscle connective tissues. Mice homozygous for a null mutation in lumican display skin laxity and fragility resembling certain types of Ehlers-Danlos syndrome. In addition, the mutant mice develop bilateral corneal opacification. The underlying connective tissue defect in the homozygous mutants is deregulated growth of collagen fibrils with a significant proportion of abnormally thick collagen fibrils in the skin and cornea as indicated by transmission electron microscopy. A highly organized and regularly spaced collagen fibril matrix typical of the normal cornea is also missing in these mutant mice. This study establishes a crucial role for lumican in the regulation of collagen assembly into fibrils in various connective tissues. Most importantly, these results provide a definitive link between a necessity for lumican in the development of a highly organized collagenous matrix and corneal transparency.


Subject(s)
Chondroitin Sulfate Proteoglycans/physiology , Collagen/metabolism , Corneal Opacity/etiology , Keratan Sulfate/physiology , Skin Diseases, Metabolic/etiology , Animals , Chondroitin Sulfate Proteoglycans/genetics , Corneal Opacity/pathology , Gene Expression , Gene Targeting , In Situ Hybridization , Keratan Sulfate/genetics , Lumican , Mice , Skin Diseases, Metabolic/pathology , Tensile Strength
7.
Proc Natl Acad Sci U S A ; 95(3): 1114-9, 1998 Feb 03.
Article in English | MEDLINE | ID: mdl-9448294

ABSTRACT

Deletion complexes consisting of multiple chromosomal deletions induced at single loci can provide a means for functional analysis of regions spanning several centimorgans in model genetic systems. A strategy to identify and map deletions at any cloned locus in the mouse is described here. First, a highly polymorphic, germ-line competent F1(129/Sv-+Tyr+p x CAST/Ei) mouse embryonic stem cell line was established. Then, x-ray and UV-induced mutagenesis was performed to determine the feasibility of generating deletion complexes throughout the mouse genome. Reported here are the selection protocols, induced mutation frequencies, cytogenetic and extensive molecular analysis of mutations at the X-chromosome-linked hypoxanthine phosphoribosyltransferase (Hprt) locus and at the neural cell adhesion molecule (Ncam) locus located on chromosome 9. Mutation analysis with PCR-based polymorphic microsatellite markers revealed deletions of <3 cM at the Hprt locus, whereas results consistent with deletions covering >28 cM were observed at the Ncam locus. Fluorescence in situ hybridization with a chromosome 9 paint revealed that some of the Ncam deletions were accompanied by complex chromosome rearrangements. In addition, deletion mapping in combination with loss of heterozygosity of microsatellite markers revealed a putative haploinsufficient region distal to Ncam. These data indicate that it is feasible to generate x-ray-induced deletion complexes in mouse embryonic stem cells.


Subject(s)
Embryo, Mammalian/radiation effects , Mutagenesis , Stem Cells/radiation effects , Animals , Cell Line , Chromosome Mapping , Dosage Compensation, Genetic , Female , Gene Deletion , Hypoxanthine Phosphoribosyltransferase/genetics , In Situ Hybridization, Fluorescence , Loss of Heterozygosity , Male , Mice , Neural Cell Adhesion Molecules/genetics , Thymidine Kinase/genetics
8.
Science ; 269(5221): 230-4, 1995 Jul 14.
Article in English | MEDLINE | ID: mdl-7618084

ABSTRACT

Gene targeting was used to create a null allele at the epidermal growth factor receptor locus (Egfr). The phenotype was dependent on genetic background. EGFR deficiency on a CF-1 background resulted in peri-implantation death due to degeneration of the inner cell mass. On a 129/Sv background, homozygous mutants died at mid-gestation due to placental defects; on a CD-1 background, the mutants lived for up to 3 weeks and showed abnormalities in skin, kidney, brain, liver, and gastrointestinal tract. The multiple abnormalities associated with EGFR deficiency indicate that the receptor is involved in a wide range of cellular activities.


Subject(s)
Abnormalities, Multiple/genetics , Embryonic and Fetal Development , ErbB Receptors/genetics , ErbB Receptors/physiology , Gene Targeting , Animals , Base Sequence , Brain/abnormalities , Brain/cytology , Cell Division , Digestive System/cytology , Digestive System Abnormalities , ErbB Receptors/deficiency , Female , Hair/abnormalities , Homozygote , Kidney/cytology , Lung/cytology , Male , Mice , Molecular Sequence Data , Mutation , Phenotype , Skin/cytology , Skin Abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL
...